share_log

Revelation Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-AXA IM Prime Impact Master Fund I SCA SICAV-RAIF(8.32%),AXA IM Prime Impact GP S.à.r.l(8.32%), etc.

Revelation Biosciences | SC 13G:超过5%持股股东披露文件-AXA IM Prime Impact Master Fund I SCA SICAV-RAIF(8.32%),AXA IM Prime Impact GP S.à.r.l(8.32%)等

2023/02/14 12:39
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息